Cargando…
Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance
Increasing evidence has shown that mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) have unique clinical implications for breast cancer subtyping and classification, as well as for breast cancer targeted therapy. It is particularly important to clarify the co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012142/ https://www.ncbi.nlm.nih.gov/pubmed/35388661 http://dx.doi.org/10.4081/ejh.2022.3315 |
_version_ | 1784687739327741952 |
---|---|
author | Kong, Xin Wang, Qi Li, Jie Li, Ming Deng, Fusheng Li, Chuanying |
author_facet | Kong, Xin Wang, Qi Li, Jie Li, Ming Deng, Fusheng Li, Chuanying |
author_sort | Kong, Xin |
collection | PubMed |
description | Increasing evidence has shown that mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) have unique clinical implications for breast cancer subtyping and classification, as well as for breast cancer targeted therapy. It is particularly important to clarify the correlation between their expression and different molecular breast carcinoma subtypes to better understand the molecular basis of the subtypes and to identify effective therapeutic targets for the disease. This study aimed to evaluate mammaglobin, GATA3, and EGFR expression in different breast cancer subtypes, as well as their clinical significance. Subjects of the study included 228 patients with breast cancer at The First Affiliated Hospital of University of Science and Technology of China. They were divided into triple negative (TN), Luminal A, Luminal B, and HER-2 positive (HER-2.P) breast cancer groups based on molecular classification. Immunohistochemical methods were used to detect mammaglobin, GATA3, and EGFR expression in cases of different molecular subtypes before determining the correlation between protein expression and subtype. Mammaglobin and GATA3 expression levels were found to significantly vary with respect to histopathological grade, lymph node status, and molecular subtype; EGFR expression was significantly correlated with breast cancer histopathological grade and molecular subtype. For breast cancer, the expression levels of mammaglobin and GATA3, as well as mammaglobin and EGFR, were significantly correlated. In addition, there was a significantly negative correlation between the expression levels of GATA3 and EGFR in breast cancer tissue samples, especially in HER-2.P samples. These findings provide a theoretical basis for assessing breast cancer clinical prognosis based on the cancer subtype, and hence, have significant practical value. |
format | Online Article Text |
id | pubmed-9012142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-90121422022-04-16 Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance Kong, Xin Wang, Qi Li, Jie Li, Ming Deng, Fusheng Li, Chuanying Eur J Histochem Article Increasing evidence has shown that mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) have unique clinical implications for breast cancer subtyping and classification, as well as for breast cancer targeted therapy. It is particularly important to clarify the correlation between their expression and different molecular breast carcinoma subtypes to better understand the molecular basis of the subtypes and to identify effective therapeutic targets for the disease. This study aimed to evaluate mammaglobin, GATA3, and EGFR expression in different breast cancer subtypes, as well as their clinical significance. Subjects of the study included 228 patients with breast cancer at The First Affiliated Hospital of University of Science and Technology of China. They were divided into triple negative (TN), Luminal A, Luminal B, and HER-2 positive (HER-2.P) breast cancer groups based on molecular classification. Immunohistochemical methods were used to detect mammaglobin, GATA3, and EGFR expression in cases of different molecular subtypes before determining the correlation between protein expression and subtype. Mammaglobin and GATA3 expression levels were found to significantly vary with respect to histopathological grade, lymph node status, and molecular subtype; EGFR expression was significantly correlated with breast cancer histopathological grade and molecular subtype. For breast cancer, the expression levels of mammaglobin and GATA3, as well as mammaglobin and EGFR, were significantly correlated. In addition, there was a significantly negative correlation between the expression levels of GATA3 and EGFR in breast cancer tissue samples, especially in HER-2.P samples. These findings provide a theoretical basis for assessing breast cancer clinical prognosis based on the cancer subtype, and hence, have significant practical value. PAGEPress Publications, Pavia, Italy 2022-04-07 /pmc/articles/PMC9012142/ /pubmed/35388661 http://dx.doi.org/10.4081/ejh.2022.3315 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Kong, Xin Wang, Qi Li, Jie Li, Ming Deng, Fusheng Li, Chuanying Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title | Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title_full | Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title_fullStr | Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title_full_unstemmed | Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title_short | Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance |
title_sort | mammaglobin, gata-binding protein 3 (gata3), and epithelial growth factor receptor (egfr) expression in different breast cancer subtypes and their clinical significance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012142/ https://www.ncbi.nlm.nih.gov/pubmed/35388661 http://dx.doi.org/10.4081/ejh.2022.3315 |
work_keys_str_mv | AT kongxin mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance AT wangqi mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance AT lijie mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance AT liming mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance AT dengfusheng mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance AT lichuanying mammaglobingatabindingprotein3gata3andepithelialgrowthfactorreceptoregfrexpressionindifferentbreastcancersubtypesandtheirclinicalsignificance |